Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India.
Agibothu Kupparam HK, Shah I, Chandrasekaran P, Mane S, Sharma S, Thangavelu BR, Vilvamani S, Annavi V, Mahalingam SM, Thiruvengadam K, Navaneethapandian PG, Gandhi S, Poojari V, Nalwalla Z, Oswal V, Giridharan P, Babu SB, Rathinam S, Frederick A, Mankar S, Jeyakumar SM. Agibothu Kupparam HK, et al. Among authors: frederick a. J Antimicrob Chemother. 2024 Nov 4;79(11):2939-2947. doi: 10.1093/jac/dkae311. J Antimicrob Chemother. 2024. PMID: 39308327
Characterization of probes associated with rifampicin resistance in M.tuberculosis detected by GenXpert from a national reference laboratory at Chennai.
Rajendran P, Kumar MP, Thiruvengadam K, Sreenivasan P, Veeraraghavan T, Ramalingam R, Hasini S, Dhanaraju T, Kuppamuthu R, Shanmugam S, Frederick A, Padmapriyadarsini C. Rajendran P, et al. Among authors: frederick a. Tuberculosis (Edinb). 2022 Mar;133:102182. doi: 10.1016/j.tube.2022.102182. Epub 2022 Feb 12. Tuberculosis (Edinb). 2022. PMID: 35182898
Trends in rifampicin and isoniazid resistance in patients with presumptive TB.
Palani N, Premkumar M, Vaishnavee V, Dinesh V, Thiruvengadam K, Lavanya J, Sridhar R, Frederick A, Sivaramakrishnan G, Mondal R, Padmapriyadarsini C, Shanmugam S. Palani N, et al. Among authors: frederick a. Int J Tuberc Lung Dis. 2022 May 1;26(5):446-453. doi: 10.5588/ijtld.21.0455. Int J Tuberc Lung Dis. 2022. PMID: 35505474
Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.
Gopalaswamy R, Palani N, Viswanathan D, Preysingh B, Rajendran S, Vijayaraghavan V, Thangavel K, Vadivel SD, Stanley H, Thiruvengadam K, Jayabal L, Murugesan K, Rathinam S, Frederick A, Sivaramakrishnan G, Padmapriyadarsini C, Shanmugam S. Gopalaswamy R, et al. Among authors: frederick a. Medicina (Kaunas). 2023 May 23;59(6):1005. doi: 10.3390/medicina59061005. Medicina (Kaunas). 2023. PMID: 37374209 Free PMC article.
Operational Challenges in Conducting a Subnational TB Prevalence Survey in India: Lessons Learned for Resource-Limited, High-Burden Settings.
Giridharan P, Murugesan H, Selvaraju S, Frederick A, Selvavinayagam TS, Nagarajan K, Thiruvengadam K, Krishnan R, Rajendran P, Kumaran P, Kumar M, Chandrasekeran P. Giridharan P, et al. Among authors: frederick a. Glob Health Sci Pract. 2024 Feb 28;12(1):e2300284. doi: 10.9745/GHSP-D-23-00284. Print 2024 Feb 28. Glob Health Sci Pract. 2024. PMID: 38272679 Free PMC article.
Programmatic implications of a sub-national TB prevalence survey in India.
Prathiksha G, Selvaraju S, Thiruvengadam K, Frederick A, Murugesan H, Rajendran P, Nagarajan K, Kumar M, Krishnan R, Kumaran P, Selvavinayagam TS, Padmapriyadarsini C. Prathiksha G, et al. Among authors: frederick a. Int J Tuberc Lung Dis. 2024 Jul 1;28(7):348-353. doi: 10.5588/ijtld.23.0456. Int J Tuberc Lung Dis. 2024. PMID: 38961546
Estimating and Explaining the Differences in Health Care Seeking by Symptom Burden Among Persons With Presumptive Tuberculosis: Findings From a Population-Based Tuberculosis Prevalence Survey in a High-Burden Setting in India.
Giridharan P, Nagarajan K, Selvaraju S, Frederick A, Subbiah E, Mani S, Thiruvengadam K, Selvavinayagam TS, Padmapriyadarsini C; Tamil Nadu TB Prevalence Study Group. Giridharan P, et al. Among authors: frederick a. Open Forum Infect Dis. 2024 Jul 19;11(8):ofae412. doi: 10.1093/ofid/ofae412. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39130083 Free PMC article.
TB prevalence is higher among smokers.
Prathiksha G, Newtonraj A, Thiruvengadam K, Frederick A, Selvaraju S. Prathiksha G, et al. Among authors: frederick a. Int J Tuberc Lung Dis. 2025 Jan 1;29(1):29-34. doi: 10.5588/ijtld.24.0359. Int J Tuberc Lung Dis. 2025. PMID: 39754282
Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides.
Radhakrishnan R, Prabuseenivasan S, Hannah S, Vaishanavee V, Senthildevi V, Kannadhasan T, Suchithra R, Rajendran P, Chinnaiyan P, Jayabal L, Frederick A, Shanmugam S. Radhakrishnan R, et al. Among authors: frederick a. Int J Mycobacteriol. 2023 Jul-Sep;12(3):299-304. doi: 10.4103/ijmy.ijmy_120_23. Int J Mycobacteriol. 2023. PMID: 37721236 Free article.
Quality of comprehensive assessment among severely ill TB patients referred after triaging in southern India.
Shewade HD, Frederick A, Kiran Pradeep S, Daniel Rajasekar T, Kiruthika G, Bhatnagar T, Suma KV, Ravichandran P, Gayathri K, Vijayaprabha R, Pathinathan DP, Chidambaram D, Sivagami K, Janani RK, Selvavinayagam TS, Ramachandran R, Murhekar MV. Shewade HD, et al. Among authors: frederick a. Public Health Action. 2024 Mar 1;14(1):3-6. doi: 10.5588/pha.23.0051. eCollection 2024 Mar. Public Health Action. 2024. PMID: 38798777 Free PMC article.
197 results